Ironwood Pharmaceuticals (IRWD) PT Lowered to $9 at Cowen, Following Business Update
Tweet
Share
E-mailGet Alerts IRWD Hot Sheet
Price: $4.12 -5.5%
Rating Summary:
11 Buy, 14 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 13 | New: 20
Rating Summary:
11 Buy, 14 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 13 | New: 20
Join SI Premium – FREE
Cowen analyst Borisk Peaker lowered the price target on Ironwood Pharmaceuticals (NASDAQ: IRWD) to $9.00 (from $12.00) while maintaining a Market Perform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Unicycive Therapeutics (UNCY) PT Raised to $15 at Benchmark Following Q2 Results
- CrowdStrike (CRWD) PT Raised to $235 at JPMorgan
- Rubrik Inc (RBRK) PT Raised to $120 at Oppenheimer; Sees Another 'Beat and Raise'
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Cowen & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
